Available Cervical Cancer Vaccines Fail to Cover the HPV 35 Genotype Common in Africa 26/03/2026 Elaine Ruth Fletcher The Human papillomavirus (HPV35), globally associated with only 2% of invasive cervical cancers (ICC), has a disproportionately higher prevalence in sub‐Saharan Africa, reaching rates of 22-30% in some countries among women with ICC lesions, according to a new study. Recently, a high-level panel called for redoubled efforts in HPV vaccination, screening and treatment to meet […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU Clinches Landmark Pharma Reform, but Industry Cites Threat to Competitiveness 12/12/2025 Felix Sassmannshausen Following eleven hours of intense negotiations overnight, the European Union (EU) clinched a landmark agreement on the most significant pharma reform of its medicines market in over 20 years on Thursday. Reached in the final moments of the Danish EU Presidency’s mandate, the deal aims to strike a critical balance stimulating pharma innovation, particularly for […] Continue reading -> Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Gavi Cuts Staff and Support to WHO and UNICEF – Gives More Freedom to Countries to Decide Vaccine Priorities 05/12/2025 Elaine Ruth Fletcher Gavi, the Vaccine Alliance has pared down its staff in its Geneva headquarters, Washington DC and New York by 33% – from 643 to 440 people, the agency confirmed today, following a June replenishment drive that fell about $2 billion short of a $11.9 billion fundraising goal for 2026-2030. Beginning in 2026, the agency will […] Continue reading -> Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Collaboration Across Africa is Key to Increasing Clinical Trials 05/12/2025 Sophia Samantaroy In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for vaccine clinical trials, often without the compensation needed to cover even their children’s school fees. Their dilemma underscores a broader challenge in Africa’s clinical research ecosystem. Slow, duplicative approval processes and limited regulatory […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> Posts navigation Older posts